Literature DB >> 28577856

Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by α4β7 integrin.

Subhash Chand1, Emily L Messina1, Wadad AlSalmi1, Neeti Ananthaswamy1, Guofen Gao1, Gherman Uritskiy1, Victor Padilla-Sanchez1, Marthandan Mahalingam1, Kristina K Peachman2, Merlin L Robb2, Mangala Rao3, Venigalla B Rao4.   

Abstract

The α4ß7 integrin present on host cells recognizes the V1V2 domain of the HIV-1 envelope protein. This interaction might be involved in virus transmission. Administration of α4ß7-specific antibodies inhibit acquisition of SIV in a macaque challenge model. But the molecular details of V1V2: α4ß7 interaction are unknown and its importance in HIV-1 infection remains controversial. Our biochemical and mutational analyses show that glycosylation is a key modulator of V1V2 conformation and binding to α4ß7. Partially glycosylated, but not fully glycosylated, envelope proteins are preferred substrates for α4ß7 binding. Surprisingly, monomers of the envelope protein bound strongly to α4ß7 whereas trimers bound poorly. Our results suggest that a conformationally flexible V1V2 domain allows binding of the HIV-1 virion to the α4ß7 integrin, which might impart selectivity for the poorly glycosylated HIV-1 envelope containing monomers to be more efficiently captured by α4ß7 integrin present on mucosal cells at the time of HIV-1 transmission.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Envelope glycoprotein; HIV vaccine; HIV-1; V1V2 domain; Virus capture; Virus entry; α4β7 integrin

Mesh:

Substances:

Year:  2017        PMID: 28577856      PMCID: PMC5526109          DOI: 10.1016/j.virol.2017.05.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  73 in total

1.  A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.

Authors:  C D Rizzuto; R Wyatt; N Hernández-Ramos; Y Sun; P D Kwong; W A Hendrickson; J Sodroski
Journal:  Science       Date:  1998-06-19       Impact factor: 47.728

2.  Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.

Authors:  I Mondor; S Ugolini; Q J Sattentau
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.

Authors:  J M Binley; R W Sanders; B Clas; N Schuelke; A Master; Y Guo; F Kajumo; D J Anselma; P J Maddon; W C Olson; J P Moore
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2.

Authors:  Hua-Xin Liao; Mattia Bonsignori; S Munir Alam; Jason S McLellan; Georgia D Tomaras; M Anthony Moody; Daniel M Kozink; Kwan-Ki Hwang; Xi Chen; Chun-Yen Tsao; Pinghuang Liu; Xiaozhi Lu; Robert J Parks; David C Montefiori; Guido Ferrari; Justin Pollara; Mangala Rao; Kristina K Peachman; Sampa Santra; Norman L Letvin; Nicos Karasavvas; Zhi-Yong Yang; Kaifan Dai; Marie Pancera; Jason Gorman; Kevin Wiehe; Nathan I Nicely; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Jaranit Kaewkungwal; Punnee Pitisuttithum; James Tartaglia; Faruk Sinangil; Jerome H Kim; Nelson L Michael; Thomas B Kepler; Peter D Kwong; John R Mascola; Gary J Nabel; Abraham Pinter; Susan Zolla-Pazner; Barton F Haynes
Journal:  Immunity       Date:  2013-01-11       Impact factor: 31.745

5.  Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation.

Authors:  Rajesh P Ringe; Rogier W Sanders; Anila Yasmeen; Helen J Kim; Jeong Hyun Lee; Albert Cupo; Jacob Korzun; Ronald Derking; Thijs van Montfort; Jean-Philippe Julien; Ian A Wilson; Per Johan Klasse; Andrew B Ward; John P Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

Review 6.  Dynamics of virus-receptor interactions in virus binding, signaling, and endocytosis.

Authors:  Steeve Boulant; Megan Stanifer; Pierre-Yves Lozach
Journal:  Viruses       Date:  2015-06-02       Impact factor: 5.048

7.  Cryptic determinant of α4β7 binding in the V2 loop of HIV-1 gp120.

Authors:  Boonrat Tassaneetrithep; Doreen Tivon; James Swetnam; Nicos Karasavvas; Nelson L Michael; Jerome H Kim; Mary Marovich; Timothy Cardozo
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

8.  Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Authors:  Jesus F Salazar-Gonzalez; Maria G Salazar; Brandon F Keele; Gerald H Learn; Elena E Giorgi; Hui Li; Julie M Decker; Shuyi Wang; Joshua Baalwa; Matthias H Kraus; Nicholas F Parrish; Katharina S Shaw; M Brad Guffey; Katharine J Bar; Katie L Davis; Christina Ochsenbauer-Jambor; John C Kappes; Michael S Saag; Myron S Cohen; Joseph Mulenga; Cynthia A Derdeyn; Susan Allen; Eric Hunter; Martin Markowitz; Peter Hraber; Alan S Perelson; Tanmoy Bhattacharya; Barton F Haynes; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

9.  Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41.

Authors:  Rogier W Sanders; Martijn M Dankers; Els Busser; Michael Caffrey; John P Moore; Ben Berkhout
Journal:  Retrovirology       Date:  2004-03-09       Impact factor: 4.602

10.  Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region.

Authors:  Ousman Jobe; Hung V Trinh; Jiae Kim; Wadad Alsalmi; Sodsai Tovanabutra; Philip K Ehrenberg; Kristina K Peachman; Guofen Gao; Rasmi Thomas; Jerome H Kim; Nelson L Michael; Carl R Alving; Venigalla B Rao; Mangala Rao
Journal:  J Leukoc Biol       Date:  2015-12-14       Impact factor: 4.962

View more
  9 in total

1.  The V2 loop of HIV gp120 delivers costimulatory signals to CD4+ T cells through Integrin α4β7 and promotes cellular activation and infection.

Authors:  Livia R Goes; Alia Sajani; Aida Sivro; Ronke Olowojesiku; Jocelyn C Ray; Ian Perrone; Jason Yolitz; Alexandre Girard; Louise Leyre; Constantinos Kurt Wibmer; Lynn Morris; Giacomo Gorini; Genoveffa Franchini; Rosemarie D Mason; Mario Roederer; Saurabh Mehandru; Marcelo A Soares; Claudia Cicala; Anthony S Fauci; James Arthos
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-07       Impact factor: 11.205

2.  Multimeric Epitope-Scaffold HIV Vaccines Target V1V2 and Differentially Tune Polyfunctional Antibody Responses.

Authors:  Ann J Hessell; Rebecca Powell; Xunqing Jiang; Christina Luo; Svenja Weiss; Vincent Dussupt; Vincenza Itri; Alisa Fox; Mariya B Shapiro; Shilpi Pandey; Tracy Cheever; Deborah H Fuller; Byung Park; Shelly J Krebs; Maxim Totrov; Nancy L Haigwood; Xiang-Peng Kong; Susan Zolla-Pazner
Journal:  Cell Rep       Date:  2019-07-23       Impact factor: 9.423

3.  Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7.

Authors:  Sakaorat Lertjuthaporn; Claudia Cicala; Donald Van Ryk; Matthew Liu; Jason Yolitz; Danlan Wei; Fatima Nawaz; Allison Doyle; Brooke Horowitch; Chung Park; Shan Lu; Yang Lou; Shixia Wang; Ruimin Pan; Xunqing Jiang; Francois Villinger; Siddappa N Byrareddy; Philip J Santangelo; Lynn Morris; Constantinos Kurt Wibmer; Kristin Biris; Rosemarie D Mason; Jason Gorman; Joseph Hiatt; Elena Martinelli; Mario Roederer; Dai Fujikawa; Giacomo Gorini; Genoveffa Franchini; Anush Arakelyan; Aftab A Ansari; Kovit Pattanapanyasat; Xiang-Peng Kong; Anthony S Fauci; James Arthos
Journal:  PLoS Pathog       Date:  2018-08-28       Impact factor: 6.823

Review 4.  V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers.

Authors:  Ralf Duerr; Miroslaw K Gorny
Journal:  Vaccines (Basel)       Date:  2019-08-06

5.  Mucosal integrin α4β7 blockade fails to reduce the seeding and size of viral reservoirs in SIV-infected rhesus macaques.

Authors:  Widade Ziani; Jiasheng Shao; Angela Fang; Patrick J Connolly; Xiaolei Wang; Ronald S Veazey; Huanbin Xu
Journal:  FASEB J       Date:  2021-02       Impact factor: 5.834

6.  Primary HIV-1 and Infectious Molecular Clones Are Differentially Susceptible to Broadly Neutralizing Antibodies.

Authors:  Jiae Kim; Venigalla B Rao; Mangala Rao
Journal:  Vaccines (Basel)       Date:  2020-12-21

Review 7.  The Role of Integrin α4β7 in HIV Pathogenesis and Treatment.

Authors:  James Arthos; Claudia Cicala; Fatima Nawaz; Siddappa N Byrareddy; Francois Villinger; Philip J Santangelo; Aftab A Ansari; Anthony S Fauci
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

8.  Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virions.

Authors:  Constantinos Kurt Wibmer; Simone I Richardson; Jason Yolitz; Claudia Cicala; James Arthos; Penny L Moore; Lynn Morris
Journal:  Nat Commun       Date:  2018-10-26       Impact factor: 14.919

9.  Methamphetamine Induces the Release of Proadhesive Extracellular Vesicles and Promotes Syncytia Formation: A Potential Role in HIV-1 Neuropathogenesis.

Authors:  Subhash Chand; Catherine DeMarino; Austin Gowen; Maria Cowen; Sarah Al-Sharif; Fatah Kashanchi; Sowmya V Yelamanchili
Journal:  Viruses       Date:  2022-03-07       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.